Skip to main content
. 2023 Jan 10;20(6):2095–2104. doi: 10.1111/iwj.14079

FIGURE 5.

FIGURE 5

MRSA USA300 Counts following treatment with aurase, placebo and untreated controls compared with baseline. □ P < .05 compared with baseline and all treatments; * P < .05 compared with baseline, placebo and untreated controls; • P < .05 compared with baseline only.